Latest Tax Refunds News

Health and Plant Protein Group Limited (HPP) reported a reduced net loss of $528,000 for FY2025, following the receipt of final proceeds from its US divestment. The Board signals plans to return capital and pursue new corporate opportunities.

Pilot Energy has received a $3.9 million Petroleum Resource Rent Tax refund linked to decommissioning activities at the Cliff Head Oil Field, reinforcing its shift toward clean energy projects.

Tombador Iron Limited has secured a significant tax refund from Brazil, boosting its cash position as it awaits further approvals on additional claims.

AXP Energy has commenced production from the Greenhorn Formation, marking a first for its Florence leases, while reporting a 15% rise in oil output and a 42% jump in quarterly revenue.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

Pilot Energy reports significant progress in transitioning the Cliff Head Oil Field to a carbon storage facility, alongside a major upgrade in WA-481P gas and oil prospective resources and a $6.8 million capital raise.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Red Metal Limited’s June 2025 Quarterly Report highlights significant metallurgical advances at its Sybella rare earth project and accelerated drilling programs across copper-gold and gold targets, supported by government grants and resource upgrades.

Pilot Energy has secured a $1.5 million debt note to bolster cash flow ahead of a substantial $4.5 million Petroleum Resource Rent Tax refund linked to the decommissioning of the Cliff Head Oil Field.

Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.

Australian Vanadium Limited (AVL) reports strong progress on its integrated vanadium project, moving closer to final feasibility and advancing its utility-scale battery storage system, Project Lumina.